# OnCo record study-2005-01 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/study-2005-01/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "study-2005-01", "NCT00358501" ;
  schema:name "Study 2005-01"@en ;
  schema:alternateName "2005-01"@en, "Defitelio Study 1"@en ;
  schema:description "Study 2005-01 showed that defibrotide helped more people survive to day 100 after a stem-cell transplant when blocked liver veins had also led to kidney or lung failure, and it was the main evidence for the US approval of Defitelio."@en ;
  schema:url <https://onco.cc/trials/study-2005-01/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT00358501>, <https://doi.org/10.1182/blood-2015-10-676924>, <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2c3db989-d7ad-41ed-9ebf-698dcf6c24ec> ;
  onco:status "positive" ;
  onco:phase "3" ;
  onco:technologies <https://onco.cc/technologies/allogeneic-hsct/>, <https://onco.cc/technologies/autologous-stem-cell-transplant/> ;
  onco:drugs <https://onco.cc/drugs/defibrotide/> ;
  onco:companies <https://onco.cc/companies/jazz/> ;
  onco:terms <https://onco.cc/terms/allogeneic-transplant/> ;
  onco:people <https://onco.cc/people/paul-richardson/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-defibrotide-2005-01-blood-2016/> .